YARW
Yarrow Bioscience Inc
NASDAQ · Healthcare · Biotechnology · US
$19.98
+9.12%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 358.21x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.64x
- Price / sales
- 349.81x
- Price / cash flow
- -9.96x
Enterprise value
- Enterprise value
- $145.7M
- EV / sales
- 302.25x
- EV / EBITDA
- -7.73x
- EV / EBIT
- -7.31x
- Market cap
- $168.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026